Edition:
United Kingdom

CRISPR Therapeutics AG (CRSP.OQ)

CRSP.OQ on NASDAQ Stock Exchange Global Market

49.60USD
23 Apr 2018
Change (% chg)

$-4.47 (-8.27%)
Prev Close
$54.07
Open
$54.00
Day's High
$54.45
Day's Low
$48.51
Volume
631,853
Avg. Vol
292,353
52-wk High
$61.24
52-wk Low
$13.50

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 32.33 0.159
Sep '17 2.39 -0.616
Jun '17 3.58 -0.559
Mar '17 2.70 -0.541
FY 2016 Dec '16 2.34 1.395
Sep '16 1.55 -0.369
Jun '16 0.80 -0.432
Mar '16 0.48 -0.212
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 6 2.77 5.30 0.00 4.00
Quarter Ending Sep-18 6 3.62 6.40 0.50 4.00
Year Ending Dec-18 7 12.36 24.00 2.00 7.94
Year Ending Dec-19 7 22.46 91.10 0.00 9.28
Earnings (per share)
Quarter Ending Jun-18 8 -0.69 -0.62 -0.80 -0.62
Quarter Ending Sep-18 8 -0.71 -0.65 -0.85 -0.61
Year Ending Dec-18 8 -2.84 -2.53 -3.31 -3.15
Year Ending Dec-19 8 -3.30 -2.32 -4.30 -3.26
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 84.02 32.74
P/E High - Last 5 Yrs. -- 293.18 45.72
P/E Low - Last 5 Yrs. -- 91.59 24.22
Beta -- 0.90 0.88
Price to Sales (TTM) 76.97 110.89 5.71
Price to Book (MRQ) 3.91 13.58 5.37
Price to Tangible Book (MRQ) 3.97 14.04 6.95
Price to Cash Flow (TTM) -- 71.40 23.32
% Owned Institutions 41.85 12.75 2.17

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.51
Dividend 5 Year Growth Rate -- 1.66 5.32
Payout Ratio(TTM) -- 15.72 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 350.57 399.08 9.21
Sales (TTM) vs TTM 1 Yr. Ago 570.49 78.82 5.69
Sales - 5 Yr. Growth Rate -- 32.16 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago -29.58 25.00 19.36
EPS (TTM) vs TTM 1 Yr. Ago 93.32 -- --
EPS - 5 Yr. Growth Rate -- 38.99 10.76
Capital Spending - 5 Yr. Growth Rate -- 40.29 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.19
Current Ratio (MRQ) 17.79 5.30 2.98
LT Debt to Equity (MRQ) 0.00 22.96 12.18
Total Debt to Equity (MRQ) 0.00 24.62 16.45
Interest Coverage (TTM) -5.27 -99.35 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.02 54.44
Gross Margin - 5 Yr. Avg. -- 51.13 52.20
EBITD Margin (TTM) -784.99 -- --
EBITD - 5 Yr. Avg -- -574.75 10.96
Operating Margin (TTM) -805.36 -718.53 4.73
Operating Margin - 5 Yr. Avg. -- -596.06 6.40
Pre-Tax Margin (TTM) -396.50 -693.00 5.57
Pre-Tax Margin - 5 Yr. Avg. -- -599.42 6.81
Net Profit Margin (TTM) -406.62 -694.22 1.87
Net Profit Margin - 5 Yr. Avg. -- -602.27 3.09
Effective Tax Rate (TTM) -- 22.62 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.21 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 109,441 22,626,821 846,830,978
Net Income/Employee (TTM) -445,011 2,971,371 99,616,195
Receivable Turnover (TTM) 2.49 20.16 5.78
Inventory Turnover (TTM) -- 2.37 3.35
Asset Turnover (TTM) 0.03 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -13.84 -1.11 10.95
Return on Assets - 5 Yr. Avg. -- -0.57 12.31
Return on Investment (TTM) -16.50 1.58 14.38
Return on Investment - 5 Yr. Avg. -- 2.21 16.10
Return on Equity (TTM) -56.05 2.41 16.07
Return on Equity - 5 Yr. Avg. -- 3.09 17.39
  1 Year 3 Year 5 Year
Sales % 1,990.69 -- --
EPS (TTM) % -194.70 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for CRISPR Therapeutics AG

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 2.99 -0.56 99 53
13 Week 21.54 15.62 99 65
26 Week 0.05 -7.55 99 77
52 Week -- -- -- 50
YTD -4.74 -16.34 80 58
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 43.31%
# of Holders: 101
Total Shares Held: 20,426,848
3 Mo. Net Change: 356,212
# New Positions: 9
# Closed Positions: 4
# Increased Positions: 12
# Reduced Positions: 9
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.